Abiopharma

Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health

New Form EFFECT - INTELLIGENT BIO SOLUTIONS INC. Filed: 2026-01-21 AccNo: 9999999995-26-000237 Size: 2 KB

New Form EFFECT - Semler Scientific, Inc. Filed: 2026-01-21 AccNo: 9999999995-26-000227 Size: 1 KB

New Form EFFECT - Semler Scientific, Inc. Filed: 2026-01-21 AccNo: 9999999995-26-000228 Size: 1 KB

New Form EFFECT - Journey Medical Corp Filed: 2026-01-21 AccNo: 9999999995-26-000243 Size: 1 KB

New Form EFFECT - Shattuck Labs, Inc. Filed: 2026-01-21 AccNo: 9999999995-26-000240 Size: 1 KB

New Form EFFECT - SOBR Safe, Inc. Filed: 2026-01-21 AccNo: 9999999995-26-000241 Size: 1 KB

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01

Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

New Form S-3MEF - Corvus Pharmaceuticals, Inc. Filed: 2026-01-21 AccNo: 0001104659-26-005527 Size: 205 KB

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Medi Lifestyle - Announcement